DOI:
10.1055/s-00029025
Journal of Pediatric Epilepsy
LinksClose Window
References
Katz ML, Coates JR, Sibigtroth CM , et al.
Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease).
J Neurosci Res 2014;
92 (11) 1591-1598
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.